These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3281419)

  • 41. Mechanism-based irreversible enzyme inhibitors.
    Rando RR
    Methods Enzymol; 1977; 46():28-41. PubMed ID: 909415
    [No Abstract]   [Full Text] [Related]  

  • 42. Conformational aspects of inhibitor design: enzyme-substrate interactions in the transition state.
    Wolfenden R
    Bioorg Med Chem; 1999 May; 7(5):647-52. PubMed ID: 10400319
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibition and activation of enzymes. The effect of a modifier on the reaction rate and on kinetic parameters.
    Fontes R; Ribeiro JM; Sillero A
    Acta Biochim Pol; 2000; 47(1):233-57. PubMed ID: 10961698
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Perspectives of data analysis of enzyme inhibition and activation, Part 1: Use of the three-dimensional K'm V'I coordinate system for data analysis of enzyme inhibition and activation.
    Krupyanko VI
    J Biochem Mol Toxicol; 2009; 23(2):97-100. PubMed ID: 19367642
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Kinetics of inhibition of aminoacylase activity by dithiothreitol or 2-mercaptoethanol.
    Yang Y; Wang HR; Zhou HM
    Int J Pept Protein Res; 1996 Dec; 48(6):532-8. PubMed ID: 8985786
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Single-molecule enzyme kinetics in the presence of inhibitors.
    Saha S; Sinha A; Dua A
    J Chem Phys; 2012 Jul; 137(4):045102. PubMed ID: 22852658
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A BASIC computer program for use in evaluating enzyme-substrate-inhibitor kinetics.
    Lutz RA; Rodbard D
    Clin Chem; 1985 Apr; 31(4):656. PubMed ID: 3838501
    [No Abstract]   [Full Text] [Related]  

  • 48. [Stationary kinetics of multisubstrate enzymatic reactions. Inhibition by reaction products, reversible and irreversible inhibitors].
    Vrzheshch PV
    Biokhimiia; 1988 Oct; 53(10):1704-11. PubMed ID: 3233227
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Irreversible inactivation of beta-lactamase I from Bacillus cereus by chlorinated 6-spiroepoxypenicillins.
    Gledhill L; Williams P; Bycroft BW
    Biochem J; 1991 Jun; 276 ( Pt 3)(Pt 3):801-7. PubMed ID: 1905929
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Perspectives of data analysis of enzyme inhibition and activation, Part 3: Equations for calculation of the initial rates of enzymatic reactions.
    Krupyanko VI
    J Biochem Mol Toxicol; 2009; 23(2):108-18. PubMed ID: 19367644
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Regulatory proteins (inhibitors or activators) affect estimates of Mr of enzymes and receptors by radiation inactivation. A theoretical model.
    Potier M; Giroux S
    Biochem J; 1985 Mar; 226(3):797-801. PubMed ID: 2985046
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis of phosphoenol pyruvate (PEP) analogues and evaluation as inhibitors of PEP-utilizing enzymes.
    García-Alles LF; Erni B
    Eur J Biochem; 2002 Jul; 269(13):3226-36. PubMed ID: 12084063
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A theoretical approach to some analytical properties of heterogeneous enzymatic assays.
    Gutiérrez OA; Chavez M; Lissi E
    Anal Chem; 2004 May; 76(9):2664-8. PubMed ID: 15117213
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Kinetics of inactivation of calf intestine alkaline phosphatase by EDTA with absorption spectrum method].
    Wang JY; Peng XJ; Yang D; An LJ; Hu JH; Zheng XF
    Guang Pu Xue Yu Guang Pu Fen Xi; 2001 Oct; 21(5):701-3. PubMed ID: 12945337
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Kinetic differentiation between enzyme inactivation involving complex-formation with the inactivator and that involving a conformation-change step.
    Liu C; Tsou CL
    Biochem J; 1992 Mar; 282 ( Pt 2)(Pt 2):501-4. PubMed ID: 1546965
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular interactions in intermediate and transition states in the self-stimulated inhibition of enzymes.
    Demuth HU; Heins J; Fujihara H; Mordy CW; Barth A; Schowen RL
    Pharmazie; 1988 Apr; 43(4):262-4. PubMed ID: 2842812
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A guide for interpreting substrate nonlinear steady-state enzyme kinetic data using random models.
    Fisher JR
    Arch Biochem Biophys; 1972 Oct; 152(2):638-45. PubMed ID: 4628999
    [No Abstract]   [Full Text] [Related]  

  • 58. Corrected equations for calculation of constants in enzyme inhibition and activation.
    Krupyanko VI
    Biochemistry (Mosc); 2007 Apr; 72(4):380-91. PubMed ID: 17511602
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Trypanosoma cruzi phospho enol pyruvate carboxykinase (ATP-dependent): transition metal ion requirement for activity and sulfhydryl group reactivity.
    Jurado LA; Machín I; Urbina JA
    Biochim Biophys Acta; 1996 Jan; 1292(1):188-96. PubMed ID: 8547343
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A microscopic model of enzyme kinetics.
    Gentry R; Ye L; Nemerson Y
    Biophys J; 1995 Aug; 69(2):356-61. PubMed ID: 8527648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.